1522
K. Michigami et al.
PAPER
Methyl 2,3-Di-O-methyl-α-D-glucopyranoside (2b)
Methyl 2,3-Di-O-methyl-β-D-glucopyranoside (6b)
32
White solid; yield: 106 mg (96%); mp 78–80 °C (Lit.9 83–85 °C);
[α]D27 +151.5 (c 1.0, H2O) [Lit.9 [α]D23 +146.4 (c 1.0, H2O)].
White solid; yield: 79 mg (71%); mp 42 °C (Lit.13 62–64 °C); [α]D
–41.3 (c 1.0, CHCl3) [Lit.13 [α]D –47.8 (CHCl3)].
IR (KBr): 699, 755, 1072, 3100–3770 cm–1.
IR (KBr): 614, 890, 955, 996, 1025, 1061, 1085, 1103, 3000–3700
cm–1.
1H NMR (400 MHz, CDCl3): δ = 2.07 (br s, 1 H, OH), 2.18 (br s, 1
H, OH), 3.23 (dd, J = 9.2, 3.2 Hz, 1 H, H2), 3.4–3.6 (m, 8 H, 2 OMe,
H3, H4), 3.6–3.7 (m, 4 H, OMe, H5), 3.81 (dd, J = 11.6, 4.0 Hz, 1
H, H6), 3.87 (dd, J = 11.6, 4.0 Hz, 1 H, H6′), 4.86 (d, J = 3.2 Hz, 1
H, H1).
13C NMR (100.6 MHz, CDCl3): δ = 55.3, 55.5, 61.3, 62.4, 76.7,
81.9, 82.7, 97.5,
1H NMR (400 MHz, CDCl3): δ = 2.28 (br s, 1 H, OH), 2.89 (br s, 1
H, OH), 3.00 (dd, J = 9.2, 7.8 Hz, 1 H, H2), 3.14 (dd, J = 9.1, 9.0
Hz, 1 H, H4), 3.3–3.4 (m, 1 H, H5), 3.51 (dd, J = 9.2, 9.1 Hz, 1 H,
H3), 3.56 (s, 3 H, OMe), 3.58 (s, 3 H, OMe), 3.64 (s, 3 H, OMe),
3.7–4.0 (m, 2 H, H6, H6′), 4.25 (d, J = 7.8 Hz, 1 H, H1).
13C NMR (100.6 MHz, CDCl3): δ = 57.2, 60.2, 60.9, 62.5, 70.1,
74.7, 83.6, 95.6, 104.6.
HRMS (ESI–): m/z [M – H]– calcd for C9H17O6: 221.1025; found:
HRMS (ESI–): m/z [M – H]– calcd for C9H17O6: 221.1025; found:
221.1025.
221.1025.
Methyl 2,3-Anhydro-α-D-glucopyranoside (3b)
White solid; yield: 65 mg (74%); mp 109 °C (Lit.10 103–105 °C);
[α]D33 +144.8 (c 0.17, CHCl3).
Methyl 2,3-Di-O-benzoyl-α-D-glucopyranoside (7b)
28
White solid; yield: 105 mg (52%); mp 63–65 °C; [α]D +178.2 (c
1.0, CHCl3) [Lit.14 [α]D19 +165.6 (CHCl3)].
IR (KBr): 616, 750, 793, 840, 894, 911, 964, 981, 1026, 1040, 1051,
1074, 1105, 1306, 1366, 2920, 2964, 3000–3500 cm–1.
IR (KBr): 696, 739, 961, 1028, 1045, 1094, 1194, 1275, 1354, 1453,
1722, 2928, 3000–3500 cm–1.
1H NMR (400 MHz, CDCl3): δ = 3.46 (s, 3 H, OMe), 3.49 (dd,
J = 4.2 Hz, 1 H, H3), 3.57 (dd, J = 3.1, 4.2 Hz, 1 H, H2), 3.6–3.7 (m,
1 H, H5), 3.80 (d, J = 3.9, 11.7 Hz, 1 H, H6), 3.86 (d, J = 3.9, 11.7
Hz, 1 H, H6′), 3.99 (d, J = 8.8 Hz, 1 H, H4), 4.91 (d, J = 3.1 Hz, 1
H, H1).
13C NMR (100.6 MHz, CDCl3): δ = 54.1, 55.5, 55.7, 62.2, 65.9,
69.0, 94.6.
1H NMR (400 MHz, CDCl3): δ = 1.72 (br s, 1 H, OH), 2.16 (br s, 1
H, OH), 3.43 (s, 3 H, OMe), 3.86 (ddd, J = 6.7, 6.7, 3.1 Hz, 1 H,
H5), 3.9–4.0 (m, 3 H, H4, H6, H6′), 5.12 (d, J = 3.9 Hz, 1 H, H1),
5.23 (dd, J = 3.9, 9.5 Hz, 1 H, H2), 5.74 (dd, J = 10.3, 9.5 Hz, 1 H,
H3), 7.3–7.4 (m, 4 H, HPh), 7.5–7.6 (m, 2 H, HPh), 7.9–8.0 (m, 4 H,
HPh).
13C NMR (100.6 MHz, CDCl3): δ = 55.4, 62.1, 69.6, 71.3, 71.5,
74.3, 97.1, 128.4, 129.08, 129.15, 129.87, 129.88, 133.3, 133.5,
166.0, 167.5.
HRMS (ESI–): m/z [M – H]– calcd for C7H11O5: 175.0606; found:
175.0603.
HRMS (ESI–): m/z [M – H]– calcd for C21H21O8: 401.1236; found:
401.1237.
Methyl 2,3-Di-O-tosyl-α-D-glucopyranoside (4b)
29
White solid; yield: 181 mg (72%); mp 55 °C; [α]D +59.6 (c 1.0,
CHCl3) [Lit.11 [α]D +58.5 (c 3.1, CHCl3)].
Methyl 2,3-Di-O-benzyl-α-D-galactopyranoside (9b)
IR (KBr): 564, 664, 732, 811, 830, 907, 972, 995, 1036, 1173, 1190,
1360, 2927, 3000–3600 cm–1.
29
Colorless oil; yield: 128 mg (68%); [α]D +46.9 (c 0.67, CHCl3)
[Lit.15 [α]D30 +43.0 (c 0.74, CHCl3)].
1H NMR (400 MHz, CDCl3): δ = 2.44 (s, 3 H, CH3), 2.46 (s, 3 H,
CH3), 3.27 (s, 3 H, OMe), 3.40 (d, J = 3.3 Hz, 1 H, OH), 3.6–3.7 (m,
1 H, H5), 3.77 (dd, J = 9.2, 9.1 Hz, 1 H, H4), 3.8–3.9 (m, 2 H, H6,
H6′), 4.30 (dd, J = 3.5, 9.4 Hz, 1 H, H2), 4.76 (d, J = 3.5 Hz, 1 H,
H1), 4.85 (dd, J = 9.4, 9.1 Hz, 1 H, H3), 7.29 (d, J = 7.6 Hz, 2 H,
PhCH2), 7.34 (d, J = 7.6 Hz, 2 H, PhCH2), 7.66 (d, J = 8.4 Hz, 2 H,
PhCH2), 7.77 (d, J = 8.4 Hz, 2 H, PhCH2).
13C NMR (100.6 MHz, CDCl3): δ = 21.70, 21.75, 55.5, 61.7, 69.2,
70.7, 75.5, 80.4, 97.0, 128.0, 128.3, 129.81, 129.84, 132.3, 132.9,
145.3, 145.4.
IR (KBr): 686, 706, 991, 1025, 1068, 1094, 1275, 1451, 1720, 2933,
3000–3500 cm–1.
1H NMR (400 MHz, CDCl3): δ = 2.46 (br s, 1 H, OH), 2.78 (br s, 1
H, OH), 3.37 (s, 3 H, OMe), 3.7–3.9 (m, 5 H, H2, H3, H5, H6, H6′),
4.0–4.1 (m, 1 H, H4), 4.67 (d, 1 H, PhCH2), 4.69 (d, J = 11.9 Hz, 1
H, PhCH2), 4.70 (d, J = 3.2 Hz, 1 H, H1), 4.81 (d, J = 11.9 Hz, 2 H,
PhCH2), 7.3–7.4 (m, 10 H, HPh).
13C NMR (100.6 MHz, CDCl3): δ = 55.3, 63.0, 68.8, 69.1, 72.9,
73.5, 75.6, 98.6, 127.8, 127.9, 128.0, 128.4, 128.5, 138.0, 138.2.
HRMS (ESI+): m/z [M + Na]+ calcd for C21H26O10S2Na: 525.0865;
found: 525.0865.
HRMS (ESI–): m/z [M – H]– calcd for C21H25O6: 373.1651; found:
373.1650.
Methyl 2,3-Di-O-acetyl-α-D-glucopyranoside (5b)
29
Colorless oil; yield: 68 mg (49%); [α]D +149.2 (c 0.46, CHCl3)
Acknowledgment
[Lit.12 [α]D19 +127 (CHCl3)].
This work was supported by a Grant-in-Aid for Scientific Research
on Innovative Areas, MEXT, Japan ‘Molecular Activation Directed
toward Straightforward Synthesis’, No. B23350043 from the Mini-
stry of Education, Culture, Sports, Science, and Technology, Japan.
Special Coordination Funds for Promoting Science and Technolo-
gy, Creation of Innovation Centers for Advanced Interdisciplinary
Research Areas (Innovative Bioproduction Kobe), MEXT, Japan is
also acknowledged.
IR (KBr): 604, 755, 918, 1029, 1223, 1370, 1742, 2932, 3000–3500
cm–1.
1H NMR (400 MHz, CDCl3): δ = 1.68 (br s, 1 H, OH), 2.10 (s, 3 H,
CH3COO), 2.11 (s, 3 H, CH3COO), 2.94 (br s, 1 H, OH), 3.41 (s, 3
H, OMe), 3.7–3.8 (m, 2 H, H4, H6), 3.8–3.9 (m, 2 H, H5, H6′), 4.84
(dd, J = 10.3, 3.3 Hz, 2 H, H2), 4.91 (d, J = 3.3 Hz, 1 H, H1), 5.2–
5.3 (m, 1 H, H3).
13C NMR (100.6 MHz, CDCl3): δ = 20.8, 20.9, 55.3, 62.0, 69.9,
70.7, 71.1, 73.4, 96.8, 170.3, 172.0.
HRMS (ESI+): m/z [M + Na]+ calcd for C11H18O8Na: 301.0899;
found: 301.0899.
Supporting Information for this article is available online at
Included
are 1H and 13C NMR spectra for compounds 1b–9b.SnugIiofop
maotrinuSgIopoimnfrtrat
r
t
Synthesis 2013, 45, 1519–1523
© Georg Thieme Verlag Stuttgart · New York